Literature DB >> 16044312

Hyperbilirubinemia and cholelithiasis in Chinese patients with hemoglobin H disease.

W Y Au1, W C Cheung, W H Hu, G C F Chan, S Y Ha, P L Khong, S K Ma, R Liang.   

Abstract

Hemoglobin H disease (HbH) is a hemoglobinopathy peculiar to parts of the world with high incidence alpha-thalassemia mutations. Among 90 HbH cases, 50 cases suffered from clinically significant jaundice (bilirubin >30 mmol/l), including 14 with severe jaundice (bilirubin >60 mmol/l). Cholelithiasis was found in 38 cases. The incidence is roughly eight times higher than that in background control population but 50% lower than that in beta-thalassemia. The risk of gallstones was related to higher bilirubin levels but not alpha-globin genotype, sex, ferritin, and hemoglobin levels. Homozygotes or double heterozygotes for Gilbert alleles (17.2%), but not heterozgyotes (42.2%), were found to have a significantly increased risk of gallstones and jaundice. However, common Chinese Gilbert syndrome alleles do not completely explain the variable risks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044312     DOI: 10.1007/s00277-005-1091-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

1.  Implementation of newborn screening for hemoglobin h disease in mainland china.

Authors:  Xing-Mei Xie; Jian-Ying Zhou; Jian Li; Ru Li; Can Liao; Dong-Zhi Li
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-20       Impact factor: 0.900

2.  A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

Authors:  Jacqueline N Milton; Paola Sebastiani; Nadia Solovieff; Stephen W Hartley; Pallav Bhatnagar; Dan E Arking; Daniel A Dworkis; James F Casella; Emily Barron-Casella; Christopher J Bean; W Craig Hooper; Michael R DeBaun; Melanie E Garrett; Karen Soldano; Marilyn J Telen; Allison Ashley-Koch; Mark T Gladwin; Clinton T Baldwin; Martin H Steinberg; Elizabeth S Klings
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Cholelithiasis in Thalassemia Major Patients: A Report from the South-East of Iran.

Authors:  Iraj Shahramian; Razieh Behzadmehr; Mahdi Afshari; Atefeh Allahdadi; Mojtaba Delaramnasab; Ali Bazi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-04-01

4.  Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and β(s) Haplotype: First Report on Comparison between Arab-Indian and African β(s) Genes.

Authors:  Said Y Alkindi; Anil Pathare; Shoaib Al Zadjali; Vinodhkumar Panjwani; Fauzia Wasim; Hammad Khan; Pradeep Chopra; Rajagopal Krishnamoorthy; Salam Alkindi
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-11-01       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.